Ghost Tree Capital’s NxStage Medical Inc. NXTM Stock Holding History

Ghost Tree Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-260,000	Closed	-$6.52M	–	89
2017 Q2	$6.52M	Buy	260,000 +60,000	+30%	+$1.49M	1.35%	28
2017 Q1	$5.37M	Buy	+200,000	New	+$5.52M	1%	41
2014 Q2	–	Sell	-62,500	Closed	-$796K	–	84
2014 Q1	$796K	Sell	62,500 -62,500	-50%	-$815K	0.47%	52
2013 Q4	$1.25M	Buy	+125,000	New	+$1.42M	0.77%	43

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ghost Tree Capital's NXTM Position: Q3 2017 in Review

Ghost Tree Capital sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 260,000 shares — an estimated $6.52M sold.

Ghost Tree Capital first reported a position in NXTM in Q4 2013 and held it in 4 quarters. The position peaked at $6.52M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Ghost Tree Capital reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Ghost Tree Capital sold 260,000 NxStage Medical Inc. shares in Q3 2017, an estimated $6.52M.
Ghost Tree Capital first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 4 quarters.
Ghost Tree Capital's NxStage Medical Inc. position peaked at $6.52M in Q2 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Ghost Tree Capital's 13F filing for Q3 2017, filed 14 Nov 2017.